These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 15806152
1. The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression. Luwor RB, Lu Y, Li X, Mendelsohn J, Fan Z. Oncogene; 2005 Jun 23; 24(27):4433-41. PubMed ID: 15806152 [Abstract] [Full Text] [Related]
2. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C, Moore JW, Robertson N, Harris AL. Cancer Res; 2001 Oct 01; 61(19):7349-55. PubMed ID: 11585776 [Abstract] [Full Text] [Related]
3. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA, Yung WK. Ann Neurol; 2003 Jan 01; 53(1):109-17. PubMed ID: 12509854 [Abstract] [Full Text] [Related]
4. Requirement of hypoxia-inducible factor-1alpha down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab. Li X, Lu Y, Liang K, Pan T, Mendelsohn J, Fan Z. Mol Cancer Ther; 2008 May 01; 7(5):1207-17. PubMed ID: 18483308 [Abstract] [Full Text] [Related]
5. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy. Secades P, de Santa-María IS, Merlo A, Suarez C, Chiara MD. Head Neck; 2015 Aug 01; 37(8):1150-62. PubMed ID: 24798801 [Abstract] [Full Text] [Related]
9. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells. Duyndam MC, van Berkel MP, Dorsman JC, Rockx DA, Pinedo HM, Boven E. Biochem Pharmacol; 2007 Jul 15; 74(2):191-201. PubMed ID: 17498666 [Abstract] [Full Text] [Related]
10. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y, Zhao X, Tang H, Zhong Z, Zhang L, Xu R, Li S, Wang Y. Urol Int; 2012 Jul 15; 88(1):95-101. PubMed ID: 22041818 [Abstract] [Full Text] [Related]
18. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK, Lee HY. J Natl Cancer Inst; 2005 Sep 07; 97(17):1272-86. PubMed ID: 16145048 [Abstract] [Full Text] [Related]